USPTO serial 99773866
CHORUS
Reviewed by CopyMark Law Group
Status 653
- Filing date
- Status date
- Registration date
- —
- Examiner
- COPELAND, ASHTON L
- Law office
- TMO LAW OFFICE 111
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with CHORUS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Dyan Finguerra-DuCharme
Dyan Finguerra-DuCharme Pryor Cashman LLP7 Times SquareNew York, NY 10036United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable computer application software for desktops, laptops and mobile devices, namely, software for monitoring and managing of advanced therapies, monitoring and managing of clinical trials related to advanced therapies, analyzing patient data, monitoring and managing prior authorizations, revenue cycle management, validating patient identification and facilitating communication between patients and healthcare providers; Downloadable computer software platforms for monitoring and managing of advanced therapies, monitoring and managing of clinical trials related to advanced therapies, analyzing patient data, monitoring and managing prior authorizations, revenue cycle management, validating patient identification and facilitating communication between patients and healthcare providers | ACTIVE | — |
| 035 | Promoting public awareness of advanced therapies; Promoting public awareness of advanced therapies by means of public advocacy; Providing business information in the field of designing, building, testing and validating processes and systems for use in advanced therapies; Business management consulting services in the field of designing, building, testing and validating processes and systems for use in advanced therapies | ACTIVE | — |
| 036 | Financing loans for healthcare groups and providers; Financial services, namely, money lending to healthcare providers, healthcare groups, pharmaceutical companies and biotechnology companies; Insurance services, namely, underwriting pharma and biotechnology property and liability insurance; Providing insurance information in the field of pharma and biotechnology property and liability insurance; Financial management in the field of collateralized loan obligation investments for healthcare providers and groups | ACTIVE | — |
| 042 | Scientific and technological services, namely, research, design, and development of remote monitoring systems and software solutions in the field of advanced therapies; Platform as a service (PAAS) featuring computer software platforms for medical professionals and healthcare providers to remotely access, analyze, and manage patient data related to advanced therapies and clinical trials related to advanced therapies; Platform as a service (PAAS) featuring computer software platforms for monitoring and managing of advanced therapies, monitoring and managing clinical trials, analyzing patient data, monitoring and managing prior authorizations, revenue cycle management, validating patient identification and facilitating communication between patients and healthcare providers; Scientific research in the nature of conducting clinical trials for others in the field of advanced therapies; Software as a service (SAAS) services featuring software for remote monitoring, data collection, monitoring and managing prior authorizations, revenue cycle management, validating patient identification, and conducting analysis of advanced therapies and clinical trials for advanced therapies | ACTIVE | — |
| 044 | Providing medical information in the field of advanced therapies; Providing a website featuring information in the field of the diagnosis and treatment of diseases using advanced therapies | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Cascade Health Technologies, Inc.
- Other trademarks in Class 009
- Other trademarks in Class 035
- Other trademarks in Class 036
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named CHORUS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 1, 2026 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Oct 1, 2026 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Oct 1, 2026 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Sep 23, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 23, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 23, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 24, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 24, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 24, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 20, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 20, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 20, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 20, 2026 | NWAP | NEW APPLICATION ENTERED | — |